首页> 外国专利> COMPOSITE BIOMARKERS FOR DIAGNOSING LUNG CANCER IN SUBJECT, LUNG CANCER DIAGNOSTIC KIT USING THE SAME, METHOD OF USING INFORMATION ON COMPOSITE BIOMARKERS, AND COMPUTING SYSTEM FOR IMPLEMENTING THE SAME

COMPOSITE BIOMARKERS FOR DIAGNOSING LUNG CANCER IN SUBJECT, LUNG CANCER DIAGNOSTIC KIT USING THE SAME, METHOD OF USING INFORMATION ON COMPOSITE BIOMARKERS, AND COMPUTING SYSTEM FOR IMPLEMENTING THE SAME

机译:诊断受试者中肺癌的复合生物标志物,使用该标志物的肺癌诊断工具箱,在该组合物生物标志物上使用信息的方法以及实施该标志物的计算机系统

摘要

PROBLEM TO BE SOLVED: To provide composite biomarkers for diagnosing lung cancer in a subject, and a lung cancer diagnostic kit using the same.SOLUTION: A lung cancer diagnostic kit that utilizes composite biomarkers to diagnose lung cancer in a subject is provided, the kit including an antibody that specifically binds to individual biomarkers CEA (Carcinoembryonic antigen), HE4 (Human epididymis Protein 4), ApoA2 (Apolipoprotein A-II), TTR (Transthyretin), sVCAM-1 (soluble Vascular Cell Adhesion Molecule-1), and RANTES (Regulated on Activation, Normal T-cell Expressed and Secreted), as well as Chemokine (C-C motif) ligand 5.SELECTED DRAWING: Figure 6
机译:解决的问题:提供用于诊断受试者中的肺癌的复合生物标志物以及使用该组合物的肺癌诊断试剂盒。解决方案:提供了一种利用复合生物标志物诊断受试者中的肺癌的肺癌诊断试剂盒,该试剂盒包括与个别生物标记物CEA(癌胚抗原),HE4(人附睾蛋白4),ApoA2(载脂蛋白A-II),TTR(运甲状腺素蛋白),sVCAM-1(可溶性血管细胞粘附分子-1)特异性结合的抗体,和RANTES(受激活,正常T细胞表达和分泌的调节)以及趋化因子(CC基序)配体5.选择绘制:图6

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号